New Findings About Somatosensory Evoked Potentials (SEP) During Surgery for Cerebral Aneurysms

August 15, 2022 updated by: Luca Valci

I Potenziali Somato-sensoriali Nella Chirurgia Degli Aneurismi Cerebrali

During surgery, electrophysiological signals will be acquired with the instrument (ISIS IOM, NeuroExplore, Software Version 4.4, Inomed) already in use at the Neurosurgery Service of the Neurocentro of the Hospital Civic Italian Switzerland in Lugano. Simultaneously to Somatosensorial Evoked Potential (SEP) will also be recorded the Electroencephalography (EEG) activity with the same detection of locations.

For the purposes of the study the signals transmitted to the neurosurgeon through the hardware and the corresponding assessments done by the neurophysiologist responsible for intraoperative monitoring will be recorded. It will also be kept track of procedures performed during surgery.

Study Overview

Status

Completed

Conditions

Study Type

Observational

Enrollment (Actual)

30

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Lugano, Switzerland, 6903
        • Neurocentro della Svizzera Italiana (NSI)

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

Patient bearer of a not broken cerebral aneurysm

Description

Inclusion Criteria:

  • Age ≥ 18 years old
  • Patient bearer of a not broken cerebral aneurysm, which has been defined per size and morphology susceptible to surgery
  • Aneurysms located on cerebral arteries of the anterior circulation (carotid, middle cerebral arteries, anterior cerebral, anterior communicating, pericallose); Cases of multiple aneurysms are also eligible
  • Informed consent for participation in the study

Exclusion Criteria:

  • Patient with an aneurysm of the posterior circulation (vertebrobasilar system)
  • The aneurysm was a source of bleeding (subarachnoid hemorrhage, intracerebral, intraventricular).
  • Patient with a pace-maker (for the risk that the electric currents used in the study could compromise the operation of the pace-maker)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
hardware performance
Time Frame: at the moment of the surgery
Collection of information on the hardware performance for reading and interpretation of the SEP and EEG signal and sending an alarm in visual form (light signal) in the eyepiece of the operating microscope during cerebral aneurysm interventions
at the moment of the surgery
Identification of sensitive electrophysiological index sensible to cerebral ischemic suffering
Time Frame: up to 3 months
study of the morphology and the analysis of the high frequency of the SEP signal
up to 3 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Study Chair: Luca Valci, MD, Ente Ospedaliero Cantonale, Bellinzona

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

May 3, 2017

Primary Completion (ACTUAL)

November 4, 2021

Study Completion (ACTUAL)

November 4, 2021

Study Registration Dates

First Submitted

May 4, 2017

First Submitted That Met QC Criteria

May 11, 2017

First Posted (ACTUAL)

May 12, 2017

Study Record Updates

Last Update Posted (ACTUAL)

August 16, 2022

Last Update Submitted That Met QC Criteria

August 15, 2022

Last Verified

August 1, 2022

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cerebral Aneurysm

Clinical Trials on electrophysiological signal

3
Subscribe